Breast Pathology Expertise

Miraca Life Sciences offers a full continuum of care for breast disease management, serving interventional radiologists, surgeons and oncologists.

For The Interventional Radiologist:

  • Pathology for core needle biopsies and fine needle aspirations
  • STAT results
  • Confirm diagnoses—benign and malignant
  • Confirm calcifications
  • ER/PR/Ki67/HER2 predictive/prognostic testing
  • Rule out other conditions
  • Metastatic breast cancers in the axilla and other sites (FNA)

For The Breast Surgeon:

  • Pathology for biopsies, needle localizations, lumpectomies and mastectomies
  • Fast turnaround time
  • Confirmation of malignancy
  • TNM staging per CAP protocols
  • Sentinel lymph node protocols (H&E, IHC)
  • ER/PR/Ki67/HER2 predictive/prognostic testing
  • Metastasis confirmation

For The Breast Oncologist:

  • ER/PR/Ki67/HER2 predictive/prognostic testing
  • Gene expression profiling (Oncotype DX®, Prosigna, MammaPrint and Mammostrat, etc. per request)
  • Tumor molecular profiling (breast cancer gene panels)
  • Hereditary breast cancer panels (9-gene)
  • Recurrence management with additional tests as needed

Learn more about our breast pathologists, breast testing, and approach to quality.

Contact us to meet with a sales director, visit our lab, send a specimen, or meet our breast pathology team.

Choose Miraca for Your Patients

Learn more about Miraca's Anatomic Pathology services

Learn More »

Miraca’s pathologists have been equally diligent with regard to tailoring their reports to the specifications of each of our physicians. They return reports in a timely fashion, communicate their concerns quickly and have excellent provider support.
— Martha J. Maso, MD, MPH,
Dermatologist, Westwood Dermatology Group, Westwood, N.J.

Learn about Miraca's unmatched quality. We provide our clients with access to the highest quality AP services.